|
|
- 2019
Polytherapy and Targeted Cancer Drug ResistanceDOI: https://doi.org/10.1016/j.trecan.2019.02.003 Abstract: The emergence of drug resistance is a barrier to effective cancer treatment. Resistance develops during chemotherapy, radiotherapy, molecularly targeted therapy, and immunotherapy in most patients with cancer and prevents their long-term survival
|
